- Global Pharma News & Resources

Infertility Drugs Market To Find Better Growth with US$ 6.2 Billion By 2026 | CAGR: 5.8%: Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Global Infertility Drugs Market, by Drug Type (Clomiphene Citrate, Sex Hormones, Gonadotropins, Bromocriptine, Cabergoline, Imipramine, Letrozole, and Metformin), by Route of Administration (Oral, Intravenous, Subcutaneous, and Intramuscular), by Gender (Male and Female), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 3.8 billion in 2017, and is estimated to exhibit a CAGR of 5.8% over the forecast period (2019-2026), as highlighted in a new report published by Coherent Market Insights.

Get FREE Sample PDF Including COVID-19 Impact Analysis:

The growth of the infertility drugs market is attributed to increasing number of research studies for development of breakthrough drugs for the treatment of infertility. For instance, according to a research conducted in Princeton University in 2018, researchers have identified a key protein in old, poor-quality Caenorhabditis elegans (microscopic worm) eggs, which controls the aging of gametes. Researchers successfully blocked this protein during the fertile period of the worm (equivalent to woman’s fertility in thirties), and extended egg viability beyond the normal span. If these protein could be removed from human genes, that could represent a 3 to 6 year extension of female fertility.

Moreover, increasing awareness about reproductive health among population is further expected to drive the infertility drugs market growth over the forecast period. For instance, RESOLVE – The National Infertility Association organizes National Infertility Awareness Week (NIAW) every year in the last week of April since 2010. The goal of the week is to raise awareness about infertility in maximum population, to encourage advocacy for insurance in infertility drugs, and help couples with infertility cope with their disease.

Browse 17 Market Data Tables and 12 Figures spread through 145 Pages and in-depth TOC on ” Global Infertility Drugs Market, By Drug Type (Clomiphene citrate, Sex hormones, Gonadotropins, Bromocriptine, Cabergoline, Imipramine, Letrozole, and Metformin), By Route of Administration (Oral, Intravenous, Subcutaneous, and Intramuscular), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2026″

To know the latest trends and insights related to the infertility drugs market press release, click the link below:

In addition, various organizations are focused on launching new programs to help infertile couples. For instance, in 2014, EMD Serono a subsidiary of Merck KGaA, Germany launched its Compassionate Corps Program, a patient assistance program to provide fertility medications for eligible U.S. veterans who were infertile due to a service-related injury. The company offers selected IVF stimulation medications at no charge for up to two IVF cycles per year. Moreover, Merck KGaA entered into a partnership with Genea Biomedx in May 2015, securing global rights to Genea’s portfolio of fertility products.

Special Requirements?
We value your investment and offer customization as per your requirements.

Share your precise requirements @

Key Takeaways of the Infertility Drugs Market:

  • The global infertility drugs market is expected to exhibit a CAGR of 5.8% over the forecast period (2019-2026), attributed to increasing research & development and new infertility drug launches by key players
  • On the basis of drug type, clomiphene citrate segment is expected account for major market share, in terms of revenue in 2026, as it is the most effective drug to treat infertility. For instance, according to a study published in the National Centre for Biotechnology Information (NCBI) in 2012, a comparative study on effectiveness of clomiphene citrate and tamoxifen in ovulation induction in infertile women showed that women treated with Clomiphene citrate showed 64% increase in pregnancy rate than the women treated with tamoxifen, which showed only 40% increase in pregnancy rate.
  • Key players operating in the global infertility drugs market include Merck & Co., Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., AbbottLaboratories, Bayer AG, and Zydus Pharmaceuticals

Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 23-Sep-2020